Radiomics to Identify Patients at Risk for Developing Pneumonitis, Differentiate Immune Checkpoint Inhibitor-induced Pneumonitis From Other Lung Inflammation and Distinguish Tumour Pseudo-progression From Real Tumour Growth
Clinical trial NCT03305380 · COMPLETED
Trial details
- NCT number
- NCT03305380
- Sponsor
- Maastricht Radiation Oncology
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-09-01
- Primary completion
- 2021-01-01
- Enrollment
- 637
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.